Pre-Treatment EEG and It's Relationship to Depression Severity and Paroxetine Treatment Outcome

An array of variables have been assessed as potential early predictors of antidepressant response in depressed patients. This exploratory study examined the relationship of clinical outcome, following pharmacotherapeutic treatment, with quantitative electroencephalographic (EEG) features assessed prior to treatment onset. In 70 major affective disorder patients, pre-treatment spectrum-analysed topographic EEG indices (absolute power, relative power, mean frequency, inter-hemispheric power asymmetry and coherence for 4 frequency bands) were assessed in relation to baseline HAM-D ratings and HAM-D rating changes following 6 weeks of open-label paroxetine treatment. EEG slow wave (theta) activities were positively correlated with depression ratings prior to treatment. Of the patients (n = 51) completing treatment, 80 % evidenced a > 50 % reduction in HAM-D ratings. Improved rating changes in general were found to be negatively related to slow (delta and theta) wave activity and positively related to fast (beta) activity at frontal recording sites. Findings are discussed in relation to the neurochemistry and neurobiology of depressive disorders.

References

• 1 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders.. Fourth Edition. American Psychiatric Association. Washington, D.C. 1994
• 2 Baxter L, Schwartz J, Phelps M, Mazziotta J, Guze B, Selin C, Gerner R H, Sumida R. Reduction of prefrontal cortex glucose metaboGsm common to three types of depression.  Arch. Gen. Psychiat.. 1989;  46 243-250
• 3 Bielski R, Friedel R. Prediction of tricyclic antidepressant response: a critical review.  Arch. Gen. Psychiat.. 1976;  88 1479-1489
• 4 Bruder G, Fong R, Tenke C E, Leite P, Towey J P, Stewart J E, McGrath P J, Quitkin F M. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study.  Biol. Psychiat.. 1997;  41 939-948
• 5 Buchsbaum M, DeLisi L E, Holcomb H, Kessler R, Johnson J, King A, Hazlett E, Langston K, Post R. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [¹⁸F] 2-deoxyglucose in affective illness.  J. Affect. Dis.. 1986;  10 137-152
• 6 Cazard P, Pollak V, Jouvent R, Leboyer M, Grob R, Lesévre N. Hemisphere asymmetry of alpha burst sequential organization in depression.  Int. J. Psychophysiol.. 1989;  8 169-183
• 7 Janke W. Clinical efficacy of drugs predicted from drug effects after short-term administration in animals, normal subjects and patients.  Neuropsychobiol.. 1985;  13 53-54
• 8 John R R, Prichep L, Easton P. Normative data banks and neurometrics: basic concepts, methods and results of norm constructions. In: Methods of analyzing bioelectric and magnetic signals.  EEG handbook, revised series, Gevins, A., A. Remond (eds.), Elsevier Science, New York. 1987;  2 449-495
• 9 Joyce P, Paykel E. Predictors of drug response in depression.  Arch. Gen. Psychiat.. 1989;  46 89-99
• 10 Kano K, Nakamura M, Matsuoka T, Iida H, Nakajima T. The topographical features of EEG in patients with affective disorders.  Electrophysiol. Clin. Neurophysiol.. 1992;  83 124-129
• 11 Knott V, Howson A, Perugini M, Ravindran A, Young S. The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects.  Biol. Psychiat.. 1999;  46 229-238
• 12 Knott V, Lapierre Y D. Computerized EEG correlates of depression and antidepressant treatment.  Prog. Neuro-Psychopharm. Biol. Psychiat.. 1987;  11 213-221
• 13 Knott V, Telner J, Lapierre Y D, Browne M, Horn E. Quantitative EEG in the prediction of antidepressant response to imipramine.  J. Affect. Dis.. 1996;  39 175-184
• 14 Kupfer D, Foster E, Reich L, Thompson K, Weiss B. EEG sleep changes as predictors in depression.  Am. J. Psychiat.. 1976;  133 622-626
• 15 Kwon J S, Youn T, Jung H Y. Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment.  J. Affect. Dis.. 1996;  40 169-173
• 16 Lindsley D. Psychological phenomena and the electroencephalogram.  Electroenceph. Clin. Neurophysiol.. 1952;  4 443-456
• 17 Martinot J-L, Hardy P, Feline A, Huret J-D, Mazoyer B, Attar-Levy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation.  Amer. J. Psychiat.. 1990;  147 1313-1317
• 18 Matousek M. EEG patterns in various subgroups of endogenous depression.  Int. J. Psychophysiol.. 1991;  10 239-243
• 19 Nieber D, Schlegel S. Relationship between psychomotor retardation and EEG power spectrum in major depression.  Neuropsychobiol.. 1992;  25 20-23
• 20 Nystrom C, Matousek M, Hällström T. Relationships between EEG and clinical characteristics in major depressive disorder.  Acta Psychiat. Scand.. 1986;  73 390-394
• 21 Nystrom C, Matousek M, Hällström T. Relationship between EEG and biochemical parameters in major depressive disorder.  Acta Psychiat. Scand.. 1988;  77 457-462
• 22 Pollock V, Schneider L. Quantitative, waking EEG research on depression.  Biol. Psychiat.. 1990;  27 757-780
• 23 Ray W, Cole H. EEG alpha activity reflects attentional demands and beta activity reflects emotional and cognitive processes.  Science. 1985;  228 750-752
• 24 Reid S, Duke L M, Allen J. Resting frontal electroencephalographic asymmetry in depression: inconsistencies suggest the need to identify mediating factors.  Psychophysiol.. 1998;  35 389-404
• 25 Schaffer C, Davidson R, Saron C. Frontal and parietal electroencephalogram in depressed and non-depressed subjects.  Biol. Psychiat.. 1983;  18 753-762
• 26 Schwartzburg M. Hemispheric laterality and EEG correlates of depression.  Res. Commun. Psychol. Psychiat. Behav.. 1983;  8 187-205
• 27 Svendsen K, Christensen P. Duration of REM sleep latency as a predictor of effect of antidepressant therapy.  Acta Psychiat. Scand.. 1981;  64 238-243
• 28 Ulrich G, Renfordt E, Zeller G, Frick K. Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression: a contribution to the predictor question.  Pharmacopsychiatr.. 1984;  17 178-183
• 29 Ulrich G, Renfordt E, Frick K. The topographical destruction of alpha activity in the resting EEG of edogenous-depressive in-patients with and without clinical response to pharmacotherapy.  Pharmacopsychiat.. 1986a;  19 272-273
• 30 Ulrich G, Renfordt E, Frick K. Electroencephalographic dynamics ofvigilance and drug-response in endogenous depression: a comparison of patients treated with amitriptyline and pirlindole.  Pharmacopsychiatr.. 1986 b;  19 270-271
• 31 Ulrich G, Hauq H, Stieglitz R, Fahndrich E. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders.  J. Affect. Disord.. 1988;  15 181-185